|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects
James CS Spratt
University of Edinburgh & University of Leicester, UK, jamesspratt@ blueyonder.co.uk
David J Webb
University of Edinburgh & University of Leicester, UK
Annette Shiels
University of Edinburgh & University of Leicester, UK
Bryan Williams
University of Edinburgh & University of Leicester, UK
Objectives
To study the effect of candesartan cilexetil on left ventricular mass index (LVMI), left ventricular systolic and diastolic function, arterial structure and function and blood pressure (BP) in hypertensive patients.
Design and methods
Patients (n=35), aged >20 years, with hypertension and average baseline LVMI of 89 g/m2 were treated for 24 weeks with candesartan, 16 mg o.d., following a four-week placebo run-in period. If diastolic BP remained above 95 mmHg, hydrochlorothiazide, 12.5 mg o.d., was added. Left ventricular structure and function were assessed using transthoracic echocardiography. Arterial function and structure were assessed using pulse wave analysis to calculate augmentation index (AIx) and forearm plethysmography to calculate minimum vascular resistance. BP was measured in the office and by 24-hour ambulatory BP monitoring (ABPM).
Results
The mean reduction in LVMI was 4.4 g/m2 (p=0.022). Left ventricular systolic function was not significantly altered from baseline, but diastolic function significantly improved: the mean change in diastolic time was 54 ms (p=0.037), in peak velocity filling 6.3 cm/s (p=0.023); E:A ratio improved by 0.08 (p=0.049). The mean reduction in forearm vascular resistance was 15 units at rest (p=0.001) and 1.3 units after limb ischaemia (p=0.006). AIx decreased significantly, with a mean reduction of 9% (p<0.001). Central BP also significantly reduced (systolic blood pressure/ diastolic blood pressure 31/20 mmHg; p<0.001). BP was significantly reduced, both in the office (22/16 mmHg; p<0.001) and by 24-hour ABPM (18/12 mmHg; p<0.001).
Conclusions
Treatment with candesartan, 16 mg o.d., with or without hydrochlorothiazide, for 24 weeks, significantly reduced left ventricular mass and arterial hypertrophy in patients with hypertension. In parallel, there were significant improvements in left ventricular diastolic function and arterial function.
Key Words: Angiotensin II receptor antagonists • left ventricular mass • hypertension • diastolic heart function • candesartan • pulse wave analysis
References
- Casals PN, Devereux RB Value of echocardiography measurement of left ventricular mass in predicting cardiovascular morbid events in hypertension. Ann Intern Med 1986;105: 173-8.[Abstract/Free Full Text]
- Ghali JK, Liao Y., Simmons B. The prognostic role of LV hypertrophy in subjects with or without coronary artery disease. Ann Intern Med 1992;117:831.[Abstract/Free Full Text]
- Fouad-Tarazi FM Left ventricular diastolic dysfunction in hypertension. Current Opin Cardiol 1994;9:551-60.[Web of Science][Medline]
[Order article via Infotrieve]
- Koren MJ, Devereux RB, Casale PN et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med 1991;114:345-52.[Abstract/Free Full Text]
- Hansson L. Reversal of cardiac and vascular hypertrophy by antihypertensive therapy. Am Heart J 1991;121:995-1000.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Levy D., Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.[Abstract]
- Verdecchia P., Schillaci G., Borgioni C. et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-55.[Abstract/Free Full Text]
- Franklin SS Ageing and hypertension: the assessment of blood pressure indices in predicting coronary artery disease. J Hypertens 1999;5:29-36.[Medline]
[Order article via Infotrieve]
- McVeigh GE, Brennan G., Hayes R. et al.Vascular abnormalities in non-insulin dependent diabetes mellitus identified by arterial waveform analysis.AmJMed 1993;95:424-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cockcroft JR, Wilkinson IB, Webb DJ Age, arterial stiffness and the endothelium.Age and Ageing 1997;26:53-60.[Free Full Text]
- Simons PCG, Algra A., Bots ML et al. Common carotid intima-media thickness and arterial stiffness: Indicators of cardiovascular risk in high-risk subjects:The SMART study (Second Manifestations of ARTerial disease). Circulation 1999;100:951-7.[Abstract/Free Full Text]
- Folkow B., Hansson L., Sivertsson R. Structural vascular factors in the pathogenesis of hypertension. Handbook of Hypertension,Vol 1; Clinical Aspects of Essential Hypertension, JIS Robertson, ed. Elsevier, Amsterdam 1983;133-50.
- Mulvany MJ, Baandrup V., Gunderson HJG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional dissector. Circ Res 1985;57:794.[Abstract/Free Full Text]
- Morishita R., Gibbons GH, Ellison KE Evidence for direct local effect of angiotensin in vascular hypertrophy. J Clin Invest 1994;94:978.[Web of Science][Medline]
[Order article via Infotrieve]
- Dahlof B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive subjects. A meta-analysis of 109 treatmentstudies.Am J Hypertens 1992;5:95-110.[Web of Science][Medline]
[Order article via Infotrieve]
- Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- O'Brien E., Mee F., Atkins N. An accurate automated device for home blood pressure measurement at last! The Omron HEM-705CP. J Hypertens 1994;12:317-18.
- Schiller NB, Shah PM, Crawford M. American Society of Echocardiography Committee on standards, subcommittee on quantification of two-dimensional echocardiograms: recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echo 1989;2:358-67.[Medline]
[Order article via Infotrieve]
- O'Rourke MF, Gallagher DE Pulse wave analysis. J Hypertens 1996;14:S147-S157.[CrossRef][Web of Science]
- Wilkinson IB, Fuchs S., Jansen I. et al.The reproducibility of augmentation index measured using applanation tonometry. J Hypertens 1998;16:279-84.
- Pedrinelli R.,Taddei S., Spessot M., Salvetti A. Maximal post-ischaemic forearm vasodilatation in human hypertension: a reassessment of the method. J Hypertens 1987;5:S431-S433.
- Agabati-Rosei E., Muisen ML, Geri A., Muiesan G. Interrelationship of cardiac and vascular wall hypertrophy in essential hypertension: effects of treatment. J Cardiovasc Pharmacol 1987;10:S116-19.[Web of Science]
- Haynes WG, Webb DJ Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Scientific Committee. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens 1990;8:666-71.
- Verdecchia P., Reboldi G., Porcellati C. et al. Prevalence and determinants of left ventricular diastolic filling abnormalities in an unselected hypertensive population. Eur Heart J 1990;11:679-91.[Abstract/Free Full Text]
- Devereux RB, Roman MJ Inter-relationships between hypertension, left ventricular hypertrophy and coronary artery disease. J Hypertens 1993;11:S3-S9.
- Tabau JF, Szlachcic J., Hirsch A., Massie BM Changes in wall thickness but not left ventricular mass predict improvement of diastolic filling in hypertension. J Am Coll Cardiol 1987;9:244.
- Strauer BE, Schwartzkopff B. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function and coronary reserve. Am J Hypertens 1998;11:879-81.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Phillips RA, Diamond JA Hypertensive heart disease. In Fuster V, Ross R, and Topol, E.J. (eds): Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott-Raven Publishers, 1996, pp 275-302.
- Pauca AL,Wallenhaupt ST, Kon ND,Tucker WY Does radial artery pressure accurately reflect aortic pressure? Chest 1992;102:1193-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mahumad A., Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens 2000;14:541-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Marceau M., Kouame N., Lacourciere Y., Cleroux J. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive subjects with left ventricular hypertrophy. J Hypertens 1998;16:673-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schiffrin EL, Park JB, Intengan HD, Touyz RM Correction of arterial structure and endothelial function in human essential hypertension by the Angiotensin receptor antagonist losartan. Circulation 2000;101:1653-9.[Abstract/Free Full Text]
- Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I- converting enzyme inhibitor. Comparison with the effects of a -blocker. Am J Hypertens 1995;8(3):229-36.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Swedberg K., Pfeffer M., Granger C. et al. Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM): Rationale and Design. J Cardiac Fail 1999;5:276-82.[CrossRef][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 4,
227-232 (2001)
DOI: 10.3317/jraas.2001.036
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
